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Abstract 
 
 
 
 
 
 
 
Coping mechanisms are patients’ means of adapting to stressful situations and 
involve psychological and physical changes in behavior. Patients adapt to head and 
neck cancer in a variety of ways. Head and neck cancers are extremely debilitating, 
especially in advanced stages of the disease or in end-of-life situations. While an 
oncology team needs to address the needs of all oncology patients, the advanced 
terminal patients require special attention. Most of these patients do not cope well 
with their situation and have a tendency to cease social interactions. Pain is the most 
frequentlyexperienced medical disability in patients having an end-stage illness 
experience, and thus an important medical endeavor is to afford dignity to the dying 
patient facingan incurable disease. In such cases, the medical community should 
never refuse therapy or to assist a dying patient.In some instances, the patient and 
family may derive benefit from their religious beliefs. 
 
 
Acne conglobata is a rare, severe form of acne vulgaris characterized by the presence of comedones, 
papules, pustules, nodules and sometimes hematic or meliceric crusts, located on the face, trunk, neck, arms 
and buttocks.  
 
Case Report 
We report the case of a 16 year old Caucasian female patient from the urban area who addressed our 
dermatology department for erythematous, edematous plaques covered by pustules and crusts, located on the 
face.  
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Introduction 
Coping mechanisms are patients’ means of adapting 
to stressful situations and typically require psychological 
and physical changes in behavior. “Bad news” typically 
leads to stress, anxiety, and depression and may instigate 
significant life changes for patients, relatives, and 
friends. Head and neck cancers are extremely 
debilitating, especially in advanced stages of the disease 
and in end-of-life situations.  
While the oncology team must address the needs of 
all oncology patients, advanced terminal patients require 
special attention. Most head and neck cancers are 
squamous cell carcinoma having various levels of 
differentiation. Supportive and palliative oncology 
therapy is intended to relieve patient suffering. A poor or 
often fatal prognosis is frequently anticipated by head 
and neck cancer patients and their families, with 
presentation of the diagnosis typically relegated to the 
specialist. Patients experience a variety of emotions 
before and after receiving the diagnosis, and even when 
considered well adjusted individuals, they may 
experience emotions ranging from shock, denial, anger, 
negociation, and acceptance to depression, anxiety, and 
even suicidal tendency. A multi-stage psychological 
model for grief iterates some of the coping strategies 
patients use when given life changing or threatening 
news (1). 
The presence of a tumor relapse or skin and soft 
tissue lack of substance, the association with necrosis 
and bad smell, purulent secretions, the presence of a 
tracheostomy or a naso-gastric feeding tube, along with 
the aesthetic scarring, all result in decreased self-esteem 
and severe impediments to social reintegration. Thus, 
head and neck cancer patients suffer poor coping ability 
and a lack of social interaction, often leading to social 
isolation.  
Discussion 
Coping with pain 
Pain is common among end-stage head and neck 
cancer patients. It is also the most frequent medical 
disability patients in end-stage illness experience and is 
one of the most important concerns for the care-givers. 
Most patients with this condition anticipate death (2, 3). 
An important medical goal is to afford dignity to a dying 
patient facing an incurable disease. Some patients view 
themselves as useless and a burden to family, friends, 
and even society. Thus, in an attempt to end 
psychological and physical suffering, they often have 
extremely low adherence to the therapy plan.  
Pain management is the primary goal of palliation 
for end-stage head and neck cancer patients, and it 
should be continued until the patient’s death in order to 
minimize suffering. Thus, a physician should never 
refuse therapy or assistance for a dying patient. Pain 
caused by malignant neoplasia is debilitating and is a 
major cause of stress, anxiety, and depression which by 
themselves may augment physical manifestations of 
pain. Clinical manifestations of pain are translated into 
altered psychological status even before the start of the 
oncology therapy (4). Pain distorts the patient’s 
personality, behavior, mood, reasoning, and coping. This 
vicious cycle may be managed by drug use and 
psychological counseling (5-7). Medication is 
administered by the oncologist after revision by the 
tumor board.  
The etiology of pain in cancer patients depends on 
the site of the primary tumor and the local or distant site 
metastasis. Pain is a complex process that starts in 
peripheral nerve terminals and has a central nervous 
system projection and integration. Although 
understanding the underlying complexity of pain 
mechanisms is not the concern of the physician, pain 
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therapy approaches can be determined by establishing 
gross models, such as idiopathic, nociceptive, 
neuropathic, psychogenic, or mixed disorders (8). Tumor 
growth generates somatic pain due to tissue injury of the 
bones, cartilages, and soft tissue of the head and neck, 
and is the most common type of pain related to head and 
neck cancers. Neuropathic pain due to abnormal 
peripheral or central nervous system stimulation is 
considered responsible for as much as 40% of pain 
syndromes related to cancer (9). While psychogenic pain 
is difficult to differentiate from idiopathic pain, the 
therapy plan is the same for both. Psychological factors 
may contribute to pain syndromes when the patient 
exhibits excessive negative thought patterns (10), 
although psychogenic pain seldom appears in head and 
neck cancer patients. Furthermore, patients tend to 
experience pain differently depending on the site of 
palliative care (11). Some studies indicate that patients 
with end-stage cancer prefer to suffer and die in a 
comfortable environment, usually their own homes (12, 
13). 
Nutrition status impairment 
End-stage head and neck cancer patients often 
experience a critical decrease in their oral intake of 
fluids and solid food, and this impoverished nutritional 
status may further induce anxiety and depression. 
Furthermore, the development of late-stage head and 
neck cancers makes oral feeding impossible due to the 
localization of the primary tumor in the upper aero-
digestive tract. The imbalance of fluid and solid food 
intake needs to be corrected by administering nutrients 
through a naso-gastric feeding tube, a classical or a 
percutaneous gastrostomy tube, or by parenteral feeding. 
Mixed nutrition, enteral and parenteral, should be used if 
the gut is functional but the necessary amount of 
nutrients cannot be achieved through enteral feeding 
alone. 
Lack of appetite is another major concern for the 
oncology team, a result of the overall biological status of 
the patient, sedation, metabolic imbalance, or altered 
mental status. As a well-fed patient copes better with the 
disease, nutrition status should be addressed as soon as 
possible. Not only is the quality of life better for patients 
who are able to feed themselves and appreciate the taste 
of food and beverages, but physicians and family are less 
anxious when a patient is able to feed himself, as most 
associate lack of food intake with advanced terminal 
illness. However, according to several authors there are 
no significant scientific data to support the idea that 
better nutrient intake increases functional and metabolic 
status or prolongs survival. Other studies even suggest 
that neither enteral nor parenteral nutrition should be 
used in terminally ill patients (12-14). 
The physician usually informs the family about the 
ongoing process of end-stage disease and reviews any 
decline in food and fluid intake. In most cases family 
and friends experience significant distress when the 
patient reaches this stage. Dehydration may be a decisive 
factor that augments suffering and hastens death in end-
stage head and neck cancer patients. If oral or enteral 
administration of fluids or rehydration solutions is 
impossible, parenteral fluid administration is required. 
Whether parenteral rehydration in end-stage illness has 
benefits on quality of life, survival, and improving 
dehydration symptoms is still being debated. In a series 
of studies, various authors have noted no differences 
between treatment and control groups regarding 
parenteral rehydration (14). 
One of the most important problems caused by oral 
intake impairment is that drugs must be administered 
through feeding tubes or parenteral catheter. Such is the 
case for pharyngoesophageal junction malignant 
neoplasia in which the digestive tract is entirely 
occupied by tumor mass. Care-givers need to ensure 
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timely administration of drugs for end-stage head and 
neck cancer patients by non-oral routes (15). 
Physician-patient relationship 
During disease diagnosis and evolution, patients 
may find themselves progressing through a variety of 
psychological stages. Coping mechanisms are used by 
patients to overcome difficult hurdles, with both coping 
strategies and emotions changing over time. The interval 
between receiving the initial diagnosis and the end-stage 
condition is characterized by emotion shifting and 
depends on the patient’s character and support from 
care-givers, family, and friends. Head and neck cancer 
patients need to adapt their decision making processes 
and mental/psychological status as they face a curable or 
an incurable disease. A positive attitude towards 
overcoming the disease is sometimes replaced with 
disbelief and abandon, leading to a relatively high 
number of patients that eventually neglect their illness 
and search for a spiritual resolution. 
Patients adapt to head and neck cancer in different 
ways. Although the cancer has multiple forms and 
stages, the attitude and psychological profile of the 
patients may not differ all that much. A number of 
studies have assessed the psychological processes and 
physical manifestations of cancer patients, thus enabling 
physicians to better understand the mental strategies 
patients use to cope with the life threatening disease 
(16). Some studies have investigated cancer patients’ 
need for information, concluding that each individual 
has a different approach to the problem. Most patients, 
however, are interested in medical data about their 
diagnosis, the therapy plan, second choice therapy, time 
interval for complete therapy, prognosis, and therapy 
consequences. Despite positive attitude towards dealing 
with their disease, patients often search for medical 
opinions that afford more hope for sustaining their 
functional status, thus electing less invasive therapies 
despite being recommended for intense, optimal 
oncology therapy. Such instances reiterate the 
importance of the physician-patient relationship and the 
need for the medical team to earn the patient’s trust to 
ensure adherence to the therapy regimen. The medical 
team must balance the pros and cons of withholding 
facts from the patient concerning the disease and the 
point at which the specialist fully informs the patient of 
the details. The appropriate time to give the patient the 
necessary information should not overlap with the time 
line for receiving the therapy. The patient’s projection of 
the disease should be shaped by the physician in terms of 
optimal therapy without interfering with the patient’s 
self-determination. The perception of the disease tends 
to modify over time, although it may show stability 
during a particular phase of disease (17). 
Relatives and social support 
Several studies have noted the importance of social 
support in developing good coping mechanisms for 
cancer patients. This support may prevent or decrease 
stress, anxiety, and depression and helps patients adhere 
to multimodal cancer therapy. Head and neck cancer 
patients represent a special category regarding family 
and social support, due to the fact that their suffering is 
highly visible.  
As the disease progresses, some patients refuse 
treatment, denying the inevitable. Patients that have 
refused primary oncological therapy typically show a 
poorer psychological profile and impaired coping 
mechanisms. Social support for end stage head and neck 
cancer patients should involve the presence of an 
integrated medical system that offers the patients both 
hospital and home assistance. In some cases, however, 
family and friends are sometimes either incapable of 
dealing with the situation or may overreact in their 
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support of the patient. There are situations in which 
patients avoid any encouragements and support from 
their family, which can lead to lack of control over their 
own medical condition. This might be extremely 
distressful for the patients and can lead to depression and 
isolation in cancer patients (18, 19). At the same time, 
facing an end-stage disease can destabilize entire 
families due to intense emotions of grief, disbelief, and 
emotional burn-out. The functionality of relationships 
within the family coping with an end-stage head and 
neck cancer member is based on love, emotional 
attachment, respect, and the capability of dealing with 
end-stage illness decision making. 
Spirituality 
Religious belief and seeking spiritual guidance are 
common among head and neck end stage cancer patients 
(20). Because religiosity in some societies is more 
prevalent among those of lower social/socioeconomic 
status (21), religious belief may play an important role 
particularly for these patients. Spirituality, even though 
less prevalent nowadays, helps some people cope with 
their disease and may afford them additional hope (20, 
22). In recent years, however, patients appear to rely 
increasingly on the scientific advances of modern 
medicine than on prayer and faith: among younger 
patients with end-stage head and neck cancer, ”God’s 
will be done” has often been replaced with ”Is there any 
medication that can help?” In fact, patients often hope 
for a ”magic” pill that can bring relief from their pain 
and suffering. The absence of religious faith may, for 
some, lead to greater suffering along with feelings of 
despair and hopelessness, which negatively affects 
coping mechanisms (23). Several studies have attempted 
to integrate a spiritual approach with medical services, 
with results suggesting a decrease in the need for highly 
invasive surgical interventions during palliative care 
(24). As various religions worldwide offer different 
perspectives regarding the end of life, patients may be 
affected quite differently by their religious tenets. 
 
Conclusions 
Psychological impairment is common in end-stage 
head and neck cancer patients. Cancer affects the whole 
body, resulting in the patient’s loss of a sense of 
integrity. Patients react idiosyncratically to threats 
regarding their way of life and eventual death, with 
reactions ranging from positive coping actions to 
unreasonable, desperate reactions. Physicians may need 
to evaluate the psychological values and needs of their 
patients to better understand the processes that drive the 
decision making regarding cancer.  
The physician-patient relationship influences the 
patient’s ability to cope with the disease. Physicians 
need to respect the rights of the patient and the principle 
of self-determination, and dignity in the face of suffering 
and death should be ensured for the life-ending patient. 
Furthermore, the physician should show respect for the 
family and their social, cultural or religious beliefs, 
especially in situations of where low health literacy, lack 
of education, or deprived socio-economic status may be 
factors. 
Palliative care can be received by head and neck 
cancer patients in E.N.T. departments, intensive care 
units, or in the intimacy of their home. Although end-
stage head and neck cancer patients receive health care 
services throughout their life-threatening disease, they 
often benefit from spending their last days in a 
comfortable environment such as their home.  
Surgical intervention for end-stage head and neck 
cancer patients may be necessary to open airway 
passages, stop hemorrhage and abscess formation, and 
ensure adequate feeding/nutrition. Essential drugs to 
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control pain, nausea, anxiety, and upper respiratory tract 
mucolysis should be prescribed as soon as needed, while 
non-essential drugs and enteral and parenteral 
supplements should be discontinued. 
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